Sysmex (Wuxi) and Ruiyali Announce Strategic Collaboration on Joint Laboratory, Quality Control Materials, and Core Raw Materials

On March 29, 2023, Sysmex Biotechnology (Wuxi) Co., Ltd., a globally renowned IVD company, and Shenzhen Ruiyali Group Co., Ltd. held a strategic cooperation signing ceremony in Shenzhen. The two parties reached a strategic partnership in the areas of joint laboratories, quality control products, and raw materials. The ceremony concluded successfully.

Sysmex has been continuously expanding its overseas markets in recent years. Localizing its operations in the Chinese market has always been part of Sysmex’s strategic planning, and the company has consistently sought to develop sustainable, stable partnerships with high-quality core raw material suppliers. By establishing a joint laboratory to address experimental challenges with special samples, proposing a comprehensive quality control product solution, and supplying high-quality raw materials, Shenzhen Ruiyali Group Co., Ltd. collaborates with Sysmex with the aim of advancing Sysmex’s localization strategy in the Chinese market.

Sysmex’s ultimate goal is to promote the health of all humanity, while Ruiyali is positioned to address the critical bottlenecks faced by downstream enterprises in IVD raw materials. Through strategic cooperation between Ruiyali and Sysmex (Wuxi) in joint laboratories, quality control products, and raw materials, we aim to introduce superior products to the Chinese market and contribute to the healthy development of China’s healthcare sector.

Sysmex Corporation (Sysmex Group) is a multinational enterprise founded in 1968, originally named Toa Medical Electronics Co., Ltd. Primarily dedicated to the field of in vitro diagnostics, it is a globally renowned provider of comprehensive clinical laboratory solutions. Headquartered in Kobe, Japan, the company currently operates more than 70 branches across China, Europe, the Americas, and the Asia-Pacific region, with its products distributed in over 190 countries worldwide.

Ruiyali, founded in 2014, is an IVD raw material platform company established by the team from the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. Headquartered in the Pingshan National Comprehensive Bonded Zone in Shenzhen, the company specializes in biological raw materials, quality control products, and customized services. Integrating “core raw materials” with “premium services,” Ruiyali operates exclusive CAS-customized IVD core raw material solutions and a bio-specialty import/export platform.

Ruiyali is committed to becoming a provider of core raw materials for the IVD industry with independent intellectual property rights in China, dedicated to making research and biotechnology production simpler, faster, and safer, thereby promoting the development of human health.